Detection of rapalog-mediated therapeutic response in renal cancer xenografts using (64)Cu-bevacizumab immunoPET

Authors

Albert J. Chang, Washington University School of Medicine in St. LouisFollow
Rebecca Sohn, Washington University School of Medicine in St. Louis
Zhi Hong Lu, Washington University School of Medicine in St. Louis
Jeffrey M. Arbeit, Washington University School of Medicine in St. Louis
Suzanne E. Lapi, Washington University School of Medicine in St. LouisFollow

Journal

PLoS One

Publication Date

2013

Volume

8

Issue

3

Inclusive Pages

e58949

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0058949

Rights and Permissions

Chang AJ, Sohn R, Lu ZH, Arbeit JM, Lapi SE (2013) Detection of Rapalog-Mediated Therapeutic Response in Renal Cancer Xenografts Using 64Cu-bevacizumab ImmunoPET. PLoS ONE 8(3): e58949. doi:10.1371/journal.pone.0058949

Recommended Citation

Chang, Albert J.; Sohn, Rebecca; Lu, Zhi Hong; Arbeit, Jeffrey M.; and Lapi, Suzanne E., "Detection of rapalog-mediated therapeutic response in renal cancer xenografts using (64)Cu-bevacizumab immunoPET." PLoS One. 8, 3. e58949. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1346